Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC), 2444 [2014-00457]
Download as PDF
<![CDATA[
2444
Federal Register / Vol. 79, No. 9 / Tuesday, January 14, 2014 / Notices
B. Solicitation of Public Comment
Respondents are encouraged to offer
their views on the following questions:
1. Is the current lack of a clear
mechanism for the procurement of
order-level materials a deterrent from
using the FSS program? If so, how?
2. What potential challenges exist for
FAS where order-level materials and the
FSS program are concerned? How can
these be addressed?
3. What kinds of processes and
procedures are in place for the
procurement of order-level materials
under other multiple-award IDIQ
contract vehicles? Can these be applied
to the FSS program as-is, or are there
special considerations FAS needs to
address? If possible, please provide
specific examples from multiple-award
IDIQ contract vehicles that could serve
as a good example of the kind of
processes and procedures needed for the
efficient and effective use of order-level
materials.
4. If FAS were to implement clear
processes and procedures for the
acquisition of order-level materials
under the FSS program, is there the
potential for administrative cost
savings? If so, please elaborate.
5. If FAS were to implement clear
processes and procedures for the
acquisition of order-level materials
under the FSS program, would it
provide increased flexibility to
contractors to provide total solutions to
Government requirements? Are there
any additional benefits for small
businesses, in particular?
6. What kind of risk management
controls are needed to ensure efficient
and effective use of order-level materials
under the FSS program?
Dated: January 8, 2014.
Houston W. Taylor,
Acting Senior Procurement Executive,
General Services Administration.
[FR Doc. 2014–00456 Filed 1–13–14; 8:45 am]
BILLING CODE 6820–61–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
emcdonald on DSK67QTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee (BCCEDCAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
VerDate Mar<15>2010
16:32 Jan 13, 2014
Jkt 232001
Time and Date: 9 a.m.–12 p.m., Eastern
Standard Time, February 3, 2014.
Place: Teleconference.
Teleconference login information is as
follows: For Participants: TOLL-FREE
PHONE #: 888–989–8135 Participant
passcode: 4798.
For Participants: URL: https://
www.mymeetings.com/nc/join/ Conference
number: PW3674736. Audience passcode:
4798.
Participants can join the event directly at:
https://www.mymeetings.com/nc/
join.php?i=PW3674736&p=4798&t=c
There is also a toll free number for anyone
outside of the USA: TOLL #: 1–203–827–
7034, Participant passcode: 4798.
Status: Open to the public, limited only by
the net conference and audio phone lines
available.
Purpose: The committee is charged with
advising the Secretary, Department of Health
and Human Services, and the Director, CDC,
regarding the early detection and control of
breast and cervical cancer. The committee
makes recommendations regarding national
program goals and objectives;
implementation strategies; and program
priorities including surveillance,
epidemiologic investigations, education and
training, information dissemination,
professional interactions and collaborations,
and policy.
Matters To Be Discussed: The agenda will
include the following: (1) Discussing the
impact of implementation of the Affordable
Care Act on the National Breast and Cervical
Cancer Early Detection Program; and (2)
exploring options to expand services to
impact women beyond the current eligible
screening population.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Jameka R. Blackmon, MBA, CMP, Designated
Federal Officer, National Center for Chronic
Disease Prevention and Health Promotion,
CDC, 4770 Buford Highway NE., Mailstop
F76, Atlanta, Georgia 30341, Telephone (770)
488–4880.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and Agency for Toxic Substances
and Disease Registry.
[FR Doc. 2014–00457 Filed 1–13–14; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: TANF Quarterly Financial
Report ACF–196R
OMB No.: New Collection
Description: This information
collection is authorized under Section
411(a)(3) of the Social Security Act. This
request is for approval to create the
ACF–196R form for quarterly financial
reporting under the Temporary
Assistance for Needy Families (TANF)
program. Implementation of these
changes will entail new costs to ACF,
and thus, final adoption will depend
upon funding availability. States
participating in the TANF program are
required by statute to report financial
data on a quarterly basis. The form
meets the legal standard and provides
essential data on the use of federal
TANF funds. Failure to collect the data
would seriously compromise ACF’s
ability to monitor program
expenditures, estimate funding needs,
and to prepare budget submissions and
annual reports required by Congress.
Financial reporting under the TANF
program is governed by 45 CFR Part
265.
Approval of the ACF–196R would
result in two basic changes to TANF
quarterly financial reports. The first is to
require respondents to allocate annual
expenditures among an expanded list of
categories on the ACF–196R; these
categories better reflect the wide range
of activities on which states are
expending TANF funds. The second
change is to the accounting method
used to report expenditures made in a
fiscal year and monitor cumulative
expenditures by grant year award.
Specifically, effective FY 2015, with
each open grant year award,
respondents will be required to report
actual expenditures made in a fiscal
year rather than updating cumulative
totals, using the ACF–196R. If a
respondent needs to adjust an
expenditure reported in a prior year, it
will revise the report for the fiscal year
in which that expenditure occurred,
rather than the current year’s report.
We will maintain the ACF–196 form
(Approved OMB No 0970–0247), only
for revisions to historical data.
Specifically, if a respondent needs to
adjust or correct an expenditure
submitted in a fiscal year prior to FY
2015, the respondent will revise the
ACF–196 pertaining to the relevant
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 79, Number 9 (Tuesday, January 14, 2014)]
[Notices]
[Page 2444]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00457]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Breast and Cervical Cancer Early Detection and Control Advisory
Committee (BCCEDCAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 9 a.m.-12 p.m., Eastern Standard Time, February
3, 2014.
Place: Teleconference.
Teleconference login information is as follows: For
Participants: TOLL-FREE PHONE : 888-989-8135 Participant
passcode: 4798.
For Participants: URL: https://www.mymeetings.com/nc/join/
Conference number: PW3674736. Audience passcode: 4798.
Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW3674736&p=4798&t=c
There is also a toll free number for anyone outside of the USA:
TOLL : 1-203-827-7034, Participant passcode: 4798.
Status: Open to the public, limited only by the net conference
and audio phone lines available.
Purpose: The committee is charged with advising the Secretary,
Department of Health and Human Services, and the Director, CDC,
regarding the early detection and control of breast and cervical
cancer. The committee makes recommendations regarding national
program goals and objectives; implementation strategies; and program
priorities including surveillance, epidemiologic investigations,
education and training, information dissemination, professional
interactions and collaborations, and policy.
Matters To Be Discussed: The agenda will include the following:
(1) Discussing the impact of implementation of the Affordable Care
Act on the National Breast and Cervical Cancer Early Detection
Program; and (2) exploring options to expand services to impact
women beyond the current eligible screening population.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Jameka R. Blackmon, MBA,
CMP, Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770 Buford Highway NE.,
Mailstop F76, Atlanta, Georgia 30341, Telephone (770) 488-4880.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and Agency for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-00457 Filed 1-13-14; 8:45 am]
BILLING CODE 4163-18-P
